Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-28 Sale | 2024-10-28 9:48 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 131,687 | $76.61 | $10,089,164 | 302,366 (Direct) | View |
2024-10-25 Sale | 2024-10-25 7:28 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $80.89 | $889,790 | 11,000 (Direct) | View |
2024-10-25 Sale | 2024-10-25 7:27 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $79.5 | $1,272,000 | 9,500 (Direct) | View |
2024-09-20 Sale | 2024-09-20 9:21 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $69.5 | $715,850 | 9,500 (Direct) | View |
2024-09-20 Sale | 2024-09-20 9:20 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 216,130 | $70.83 | $15,308,553 | 2,369,927 (Direct) | View |
2024-08-21 Sale | 2024-08-22 7:23 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $69.9 | $69,900 | 2,586,057 (Direct) | View |
2024-08-21 Sale | 2024-08-22 7:23 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $69.72 | $397,430 | 19,800 (Direct) | View |
2024-08-19 Sale | 2024-08-19 8:13 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $65.8 | $7,426,508 | 2,587,057 (Direct) | View |
2024-08-19 Sale | 2024-08-19 8:11 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $62.22 | $995,453 | 9,500 (Direct) | View |
2024-08-14 Sale | 2024-08-14 8:03 pm | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $57.53 | $1,195,736 | 9,500 (Direct) | View |
2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,136 | $57.15 | $922,212 | 187,052 (Direct) | View |
2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 115,859 | $57.58 | $6,670,604 | 2,354,927 (Direct) | View |
2024-07-30 Sale | 2024-07-31 4:05 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 18,026 | $57.13 | $1,029,912 | 362,149 (Direct) | View |
2024-05-03 Sale | 2024-05-03 8:51 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 66,756 | $74.69 | $4,986,008 | 239,105 (Direct) | View |
2024-05-01 Sale | 2024-05-02 9:27 pm | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 281,425 | $78.66 | $22,136,474 | 607,083 (Direct) | View |
2024-02-09 Sale | 2024-02-09 8:59 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 45,000 | $29.9 | $1,345,500 | 2,139,882 (Direct) | View |
2024-02-08 Sale | 2024-02-08 7:40 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 269,079 | $26.87 | $7,230,784 | 2,184,882 (Direct) | View |
2024-02-08 Sale | 2024-02-08 7:38 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $28.05 | $701,250 | 0 (Direct) | View |
2024-01-31 Sale | 2024-01-31 8:39 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $24.71 | $2,100,750 | 2,279,030 (Direct) | View |
2024-01-30 Sale | 2024-01-30 9:05 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $23.95 | $838,250 | 2,364,030 (Direct) | View |
2024-01-19 Sale | 2024-01-19 8:35 pm | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $23.05 | $691,500 | 25,000 (Direct) | View |
2024-01-04 Sale | 2024-01-04 9:35 pm | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 15,000 | $17.9 | $268,500 | 335,730 (Direct) | View |
2023-05-16 Sale | 2023-05-18 6:31 pm | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $25 | $1,000,000 | 30,000 (Direct) | View |
2023-05-16 Sale | 2023-05-18 6:30 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $24 | $384,000 | 47,965 (Direct) | View |
2023-05-01 Sale | 2023-05-01 7:03 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 45,000 | $22.45 | $1,010,250 | 2,197,963 (Direct) | View |
2023-04-24 Sale | 2023-04-24 7:31 pm | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $22 | $352,061 | 47,965 (Direct) | View |
2023-04-19 Sale | 2023-04-21 7:29 pm | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $21.45 | $750,750 | 2,242,963 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-28 Exercise | 2024-10-28 9:48 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 94,001 | $0 | 302,366 (Direct) | View |
2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 26,000 | $5.8 | 302,366 (Direct) | View |
2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 51,000 | $8.52 | 302,366 (Direct) | View |
2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,251 | $4.68 | 302,366 (Direct) | View |
2024-10-28 Exercise | 2024-10-28 9:48 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 12,750 | $7.77 | 302,366 (Direct) | View |
2024-10-25 Exercise | 2024-10-25 7:28 pm | 2023-01-03 2032-01-03 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $0 | 11,000 (Direct) | View |
2024-10-25 Exercise | 2024-10-25 7:28 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 11,000 | $4.88 | 11,000 (Direct) | View |
2024-10-25 Exercise | 2024-10-25 7:27 pm | 2019-01-02 2028-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $0 | 9,500 (Direct) | View |
2024-10-25 Exercise | 2024-10-25 7:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $4.48 | 9,500 (Direct) | View |
2024-09-20 Exercise | 2024-09-20 9:21 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $0 | 9,500 (Direct) | View |
2024-09-20 Exercise | 2024-09-20 9:21 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 10,300 | $1.19 | 9,500 (Direct) | View |
2024-09-20 Exercise | 2024-09-20 9:20 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 166,130 | $0 | 2,369,927 (Direct) | View |
2024-09-20 Exercise | 2024-09-20 9:20 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 166,130 | $7.77 | 2,369,927 (Direct) | View |
2024-08-21 Exercise | 2024-08-22 7:23 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $0 | 2,586,057 (Direct) | View |
2024-08-21 Exercise | 2024-08-22 7:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 1,000 | $7.77 | 2,586,057 (Direct) | View |
2024-08-21 Exercise | 2024-08-22 7:23 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $0 | 19,800 (Direct) | View |
2024-08-21 Exercise | 2024-08-22 7:23 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 5,700 | $1.19 | 19,800 (Direct) | View |
2024-08-19 Exercise | 2024-08-19 8:13 pm | 2021-01-03 2030-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $0 | 2,587,057 (Direct) | View |
2024-08-19 Exercise | 2024-08-19 8:13 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 112,870 | $7.77 | 2,587,057 (Direct) | View |
2024-08-19 Exercise | 2024-08-19 8:11 pm | 2017-01-04 2026-01-04 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $0 | 9,500 (Direct) | View |
2024-08-19 Exercise | 2024-08-19 8:11 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 16,000 | $3.33 | 9,500 (Direct) | View |
2024-08-14 Exercise | 2024-08-14 8:03 pm | 2016-05-26 2025-04-28 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $0 | 9,500 (Direct) | View |
2024-08-14 Exercise | 2024-08-14 8:03 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 20,786 | $8 | 9,500 (Direct) | View |
2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 28,334 | $0 | 187,052 (Direct) | View |
2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 204,333 | $0 | 2,354,927 (Direct) | View |
2024-07-29 Option Award | 2024-07-31 4:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 362,149 (Direct) | View |
2024-05-03 Exercise | 2024-05-03 8:51 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 34,249 | $0 | 239,105 (Direct) | View |
2024-05-03 Exercise | 2024-05-03 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 30,000 | $4.88 | 239,105 (Direct) | View |
2024-05-03 Exercise | 2024-05-03 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 4,249 | $4.68 | 239,105 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | 2021-03-31 2030-03-31 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 281,425 | $0 | 607,083 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 87,000 | $4.88 | 607,083 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 90,000 | $5.8 | 607,083 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 51,000 | $8.52 | 607,083 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 17,999 | $4.68 | 607,083 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 9:27 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 35,426 | $7.77 | 607,083 (Direct) | View |
2024-03-27 Tax Withholding | 2024-03-27 8:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 16,610 | $83.34 | 363,565 (Direct) | View |
2024-03-27 Option Award | 2024-03-27 8:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 363,565 (Direct) | View |
2024-03-27 Tax Withholding | 2024-03-27 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 153,948 | $83.34 | 2,266,453 (Direct) | View |
2024-03-27 Option Award | 2024-03-27 8:51 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 221,667 | $0 | 2,266,453 (Direct) | View |
2024-03-27 Tax Withholding | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 16,610 | $83.34 | 207,361 (Direct) | View |
2024-03-27 Option Award | 2024-03-27 8:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 207,361 (Direct) | View |
2024-03-01 Option Award | 2024-03-04 7:54 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 221,667 | $0 | 2,198,734 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-04 7:54 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 162,815 | $85.22 | 2,198,734 (Direct) | View |
2024-03-01 Option Award | 2024-03-04 7:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 31,667 | $0 | 348,508 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-04 7:52 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 16,958 | $85.22 | 348,508 (Direct) | View |
2024-03-01 Option Award | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 31,667 | $0 | 192,304 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-04 7:50 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 20,093 | $85.22 | 192,304 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:40 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 140,000 | $4.65 | 2,184,882 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:40 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 189,079 | $0 | 2,184,882 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:40 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 49,079 | $1.23 | 2,184,882 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:38 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $0 | 0 (Direct) | View |
2024-02-08 Exercise | 2024-02-08 7:38 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 25,000 | $8.32 | 0 (Direct) | View |
2024-01-31 Exercise | 2024-01-31 8:39 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $0 | 2,279,030 (Direct) | View |
2024-01-31 Exercise | 2024-01-31 8:39 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 85,000 | $1.23 | 2,279,030 (Direct) | View |
2024-01-30 Exercise | 2024-01-30 9:05 pm | 2018-01-05 2027-01-05 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $0 | 2,364,030 (Direct) | View |
2024-01-30 Exercise | 2024-01-30 9:05 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 35,000 | $1.23 | 2,364,030 (Direct) | View |
2024-01-19 Exercise | 2024-01-19 8:35 pm | 2020-07-01 2029-07-01 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $0 | 25,000 (Direct) | View |
2024-01-19 Exercise | 2024-01-19 8:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 30,000 | $8.32 | 25,000 (Direct) | View |
2024-01-03 Option Award | 2024-01-04 9:37 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 670,000 | $0 | 2,624,882 (Direct) | View |
2024-01-04 Tax Withholding | 2024-01-04 9:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 39,552 | $18.58 | 2,624,882 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 9:37 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Lian Brian President & CEO | 214,640 | $17.4 | 2,624,882 (Direct) | View |
2024-01-03 Option Award | 2024-01-04 9:36 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 253,334 | $0 | 488,799 (Direct) | View |
2024-01-04 Tax Withholding | 2024-01-04 9:36 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 14,199 | $18.58 | 488,799 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 9:36 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Mancini Marianna Chief Operating Officer | 49,210 | $17.4 | 488,799 (Direct) | View |
2024-01-03 Option Award | 2024-01-04 9:35 pm | 2025-01-03 2034-01-03 | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 253,334 | $0 | 335,730 (Direct) | View |
2024-01-04 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 13,872 | $18.58 | 335,730 (Direct) | View |
2024-01-03 Tax Withholding | 2024-01-04 9:35 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | ZANTE GREG Chief Financial Officer | 49,122 | $17.4 | 335,730 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:28 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | SINGLETON J MATTHEW Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:27 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:25 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | Rouan Sarah Kathryn Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:24 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 32,000 | $0 | 32,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-04 9:22 pm | 2025-01-02 2034-01-02 | Viking Therapeutics Inc. | VKTX | FOEHR MATTHEW W Director | 32,000 | $0 | 32,000 (Direct) | View |
2023-05-16 Exercise | 2023-05-18 6:31 pm | 2018-07-01 2027-07-01 | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $0 | 30,000 (Direct) | View |
2023-05-16 Exercise | 2023-05-18 6:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | Rowland Charles A Jr Director | 40,000 | $1.08 | 30,000 (Direct) | View |
2023-05-16 Exercise | 2023-05-18 6:30 pm | 2018-01-03 2027-01-03 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $0 | 47,965 (Direct) | View |
2023-05-16 Exercise | 2023-05-18 6:30 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $1.19 | 47,965 (Direct) | View |
2023-04-24 Exercise | 2023-04-24 7:31 pm | 2017-01-04 2026-01-04 | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $0 | 47,965 (Direct) | View |
2023-04-24 Exercise | 2023-04-24 7:31 pm | N/A N/A | Viking Therapeutics Inc. | VKTX | MACARTNEY LAWSON Director | 16,000 | $3.33 | 47,965 (Direct) | View |